Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma
Abstract
Share and Cite
Hotte, S.J.; Bjarnason, G.A.; Heng, D.Y.C.; Jewett, M.A.S.; Kapoor, A.; Kollmannsberger, C.; Maroun, J.; Mayhew, L.A.; North, S.; Reaume, M.N.; et al. Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma. Curr. Oncol. 2011, 18, 11-19. https://doi.org/10.3747/co.v18is2.958
Hotte SJ, Bjarnason GA, Heng DYC, Jewett MAS, Kapoor A, Kollmannsberger C, Maroun J, Mayhew LA, North S, Reaume MN, et al. Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma. Current Oncology. 2011; 18(s2):11-19. https://doi.org/10.3747/co.v18is2.958
Chicago/Turabian StyleHotte, S.J., G.A. Bjarnason, D.Y.C. Heng, M.A.S. Jewett, A. Kapoor, C. Kollmannsberger, J. Maroun, L.A. Mayhew, S. North, M.N. Reaume, and et al. 2011. "Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma" Current Oncology 18, no. s2: 11-19. https://doi.org/10.3747/co.v18is2.958